Acrivon Therapeutics, Inc. (ACRV) SEC filings
ACRV SEC filings moved a median of -2.54% by the close. ACRV SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the ACRV overview →
59 measured ACRV SEC filing events.
Where these ACRV SEC filings landedvs 59 measured ACRV SEC filing reactions
| Middle 50% of ACRV SEC filing reactions | -9.68% to +1.80% |
|---|---|
| Median reaction (to close) | -2.54% |
| Measured reactions | 59 |
Point-in-time · zero look-ahead
Half of the 59 ACRV SEC filing events with a measured close landed between -9.68% and +1.80%; 39% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Acrivon Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | -1.52% | +6.94% | |
| Form 8-K Acrivon Therapeutics, For: Aug 12 | SEC filing · Form 8-K | -1.52% | +6.94% | |
| Form S-8 Acrivon Therapeutics, | SEC filing · Form S-8 | -1.52% | +6.94% | |
| Form 8-K Acrivon Therapeutics, For: Jun 17 | SEC filing · Form 8-K | +0.65% | +1.95% | |
| Form DEFA14A Acrivon Therapeutics, | SEC filing · Form DEFA14A | -0.57% | -4.57% | |
| Form 10-Q Acrivon Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | +2.54% | -2.54% | |
| Form 8-K Acrivon Therapeutics, For: May 13 | SEC filing · Form 8-K | +2.54% | -2.54% | |
| Form ARS Acrivon Therapeutics, For: Dec 31 | SEC filing · Form ARS | +0.82% | +1.65% | |
| Form DEF 14A Acrivon Therapeutics, For: Jun 17 | SEC filing · Form DEF | +0.82% | +1.65% | |
| Form DEFA14A Acrivon Therapeutics, | SEC filing · Form DEFA14A | +0.82% | +1.65% | |
| Form 10-K Acrivon Therapeutics, For: Dec 31 | SEC filing · Form 10-K | -0.63% | +7.59% | |
| Form 8-K Acrivon Therapeutics, For: Mar 19 | SEC filing · Form 8-K | -0.63% | +7.59% | |
| Form S-8 Acrivon Therapeutics, | SEC filing · Form S-8 | -0.63% | +7.59% | |
| Form 8-K Acrivon Therapeutics, For: Feb 25 | SEC filing · Form 8-K | -2.03% | +12.84% | |
| Form 8-K Acrivon Therapeutics, For: Feb 27 | SEC filing · Form 8-K | -2.51% | -15.64% | |
| Form 8-K Acrivon Therapeutics, For: Jan 08 | SEC filing · Form 8-K | -18.57% | -31.07% | |
| Form 8-K Acrivon Therapeutics, For: Sep 05 | SEC filing · Form 8-K | -3.03% | +19.33% | |
| Form 10-Q Acrivon Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | -3.65% | +1.46% | |
| Form 8-K Acrivon Therapeutics, For: Aug 13 | SEC filing · Form 8-K | -3.65% | +1.46% | |
| Form 8-K Acrivon Therapeutics, For: Jun 13 | SEC filing · Form 8-K | -3.63% | -1.61% | |
| Form 10-Q Acrivon Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | -3.07% | -3.51% | |
| Form 8-K Acrivon Therapeutics, For: May 14 | SEC filing · Form 8-K | -3.07% | -3.51% | |
| Form S-8 Acrivon Therapeutics, | SEC filing · Form S-8 | -3.07% | -3.51% | |
| Form ARS Acrivon Therapeutics, For: Dec 31 | SEC filing · Form ARS | -8.21% | -18.41% | |
| Form DEF 14A Acrivon Therapeutics, For: Jun 13 | SEC filing · Form DEF | -8.21% | -18.41% | |
| Form DEFA14A Acrivon Therapeutics, | SEC filing · Form DEFA14A | -8.21% | -18.41% | |
| Form 8-K Acrivon Therapeutics, For: Apr 07 | SEC filing · Form 8-K | -4.03% | -8.72% | |
| Form S-8 Acrivon Therapeutics, | SEC filing · Form S-8 | -6.65% | -9.68% | |
| Form 10-K Acrivon Therapeutics, For: Dec 31 | SEC filing · Form 10-K | -6.65% | -9.68% | |
| Form 8-K Acrivon Therapeutics, For: Mar 27 | SEC filing · Form 8-K | -6.65% | -9.68% | |
| Form 8-K Acrivon Therapeutics, For: Mar 25 | SEC filing · Form 8-K | -11.65% | -40.95% | |
| Form 8-K Acrivon Therapeutics, For: Mar 11 | SEC filing · Form 8-K | +0.00% | -0.36% | |
| Form 10-Q Acrivon Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | -2.46% | -7.03% | |
| Form 8-K Acrivon Therapeutics, For: Nov 13 | SEC filing · Form 8-K | -2.46% | -7.03% | |
| Form 8-K Acrivon Therapeutics, For: Oct 11 | SEC filing · Form 8-K | -0.71% | +3.55% | |
| Form 8-K Acrivon Therapeutics, For: Sep 14 | SEC filing · Form 8-K | +2.16% | -13.37% | |
| Form 10-Q Acrivon Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | — | -11.15% | |
| Form 8-K Acrivon Therapeutics, For: Aug 13 | SEC filing · Form 8-K | — | -11.15% | |
| Form 8-K Acrivon Therapeutics, For: Jun 20 | SEC filing · Form 8-K | +0.15% | +1.07% | |
| Form 10-Q Acrivon Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | -0.48% | +0.48% | |
| Form 8-K Acrivon Therapeutics, For: May 14 | SEC filing · Form 8-K | -0.48% | +0.48% | |
| Form EFFECT Acrivon Therapeutics, | SEC filing · Form EFFECT | +2.05% | -6.96% | |
| Form ARS Acrivon Therapeutics, For: Dec 31 | SEC filing · Form ARS | +0.04% | -0.82% | |
| Form DEF 14A Acrivon Therapeutics, For: Jun 20 | SEC filing · Form DEF | +0.04% | -0.82% | |
| Form DEFA14A Acrivon Therapeutics, | SEC filing · Form DEFA14A | +0.04% | -0.82% | |
| Form 8-K Acrivon Therapeutics, For: Apr 24 | SEC filing · Form 8-K | -13.20% | -11.95% | |
| Form S-3 Acrivon Therapeutics, | SEC filing · Form S-3 | +0.05% | +3.23% | |
| Form 8-K Acrivon Therapeutics, For: Apr 08 | SEC filing · Form 8-K | -8.12% | -3.51% | |
| Form S-8 Acrivon Therapeutics, | SEC filing · Form S-8 | +2.82% | +2.26% | |
| Form 10-K Acrivon Therapeutics, For: Dec 31 | SEC filing · Form 10-K | -4.45% | +13.67% | |
| Form 8-K Acrivon Therapeutics, For: Mar 28 | SEC filing · Form 8-K | -4.45% | +13.67% | |
| Form 8-K Acrivon Therapeutics, For: Mar 04 | SEC filing · Form 8-K | +4.76% | -10.30% | |
| Form 8-K Acrivon Therapeutics, For: Feb 07 | SEC filing · Form 8-K | — | -3.28% | |
| Form 8-K Acrivon Therapeutics, For: Jan 08 | SEC filing · Form 8-K | +0.00% | -7.69% | |
| Form EFFECT Acrivon Therapeutics, | SEC filing · Form EFFECT | +0.00% | -1.72% | |
| Form 8-K Acrivon Therapeutics, For: Dec 04 | SEC filing · Form 8-K | +0.00% | -3.75% | |
| Form S-3 Acrivon Therapeutics, | SEC filing · Form S-3 | +0.00% | +14.16% | |
| Form 10-Q Acrivon Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +0.00% | -15.93% | |
| Form 8-K Acrivon Therapeutics, For: Nov 09 | SEC filing · Form 8-K | +0.00% | -15.93% |
Keep exploring
More ACRV: earnings → · analyst actions → · ACRV overview →